CoChat

Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme

Younis, N., Broadbent, D. M., Harding, S. P., Vora, J. P. · 2003 · Diabetic Medicine
Cited by 103

The DOI matches its Crossref record.

Abstract

Aim To measure the cumulative incidence of any retinopathy, maculopathy and sight‐threatening diabetic retinopathy (STDR), and calculate optimal screening intervals by retinopathy grade at baseline for patients with Type 1 diabetes attending an established systematic retinal screening programme. Methods All patients with Type 1 diabetes registered with enrolled general practitioners, excluding only those attending an ophthalmologist, were studied if retinopathy data was available at baseline and at least one further screen event. Screening utilized non‐stereoscopic 3‐field mydriatic photography and modified Wisconsin grading. STDR was defined as moderate pre‐proliferative retinopathy or greater and/or significant maculopathy in any eye. Results Patients (n = 501) underwent 2742 screen events. Cumulative incidence of STDR in patients without baseline retinopathy was 0.3% (95% CI 0.0–0.9) at 1 year, rising to 3.9% (1.4–5.4) at 5 years. Rates of progression to STDR in patients with background and mild pre‐proliferative retinopathy at 1 year were 3.6% (0.5–6.6) and 13.5% (4.2–22.7), respectively. Progression to STDR was greater in patients with a higher grade of baseline retinopathy (P = 0.001) or a longer disease duration (P = 0.003). For a 95% likelihood of remaining free of STDR, mean screening intervals by baseline status were: no retinopathy 5.7 (95% CI 3.5–7.6) years, background 1.3 (0.4–2.0) years and mild pre‐proliferative 0.4 (0–0.8) years. Conclusions Screening at 2–3 year intervals, rather than annually, for patients without retinopathy in Type 1 diabetes is feasible because of the low risk of progression to STDR, and may result in significant cost savings for a screening programme. Patients with higher grades of retinopathy require screening at least annually or more frequent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.2003.01035.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 103

Metadata

Authors
Younis, N., Broadbent, D. M., Harding, S. P., & Vora, J. P.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2003-08-19
Volume
20
Issue
9
Pages
758-765
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1953868286
Cited by
103
References
0
FWCI
4.10
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme. https://app.cochat.ai/papers/10.1046/j.1464-5491.2003.01035.x
The paper
Younis, N., Broadbent, D. M., Harding, S. P., & Vora, J. P. (2003). Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2003.01035.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.